Senior leader with strong engineering and pharmaceutical background. Technical Chemist by training, with more than 20 years of experience in pharma engineering, validation, manufacturing, M&A integration, project & change management and technology transfers in a highly regulated cGMP environment. Very motivated and dynamic with hands-on mentality "get things done". Always curious about new knowledge, new technologies, new experiences and connecting with other people. Currently supporting with a newly established corporate team Aenova’s capacities expansions projects and modernization and maintenance strategy.

Pop in Your Job: Ensure patients supply with medicine! Working with talented and experienced people in a matrix organization. Mastering everyday new challenges and opportunities. No day is like the day before. Discovering new technologies and new ways of working and thinking. Be connected with the people on the shop floor and managing the stakeholder well. Allow myself and employees to learn from unsuccessful endeavors. Happy to work in a safe, diverse and healthy environment.

The Aenova Group is a leading global contract manufacturer and development services provider for the pharmaceutical and healthcare industry. Our services include end-to-end manufacturing and development of all dosage forms and potency levels (ranging from nutraceuticals to high-potents) out of 14 sites in Europe and the US. With our comprehensive know-how, many years of experience, well-trained staff of 4,000 employees, innovative technologies and highest quality standards we are a reliable, long-term partner to pharmaceutical and consumer health care customers around the world, both in the human and veterinary healthcare market Our products and behaviour affect and improve the health and well-being of millions of patients, and their families around the world. Our customers entrust us with the responsibility to deliver life-saving or life-enhancing products. We come to work every day to serve these customers, but ultimately, because we passionately care about their patients. Aenova was created 2008, as a merger of pharmaceutical companies Dragenopharm and Swiss Caps, forming the nucleus of the group. In 2012, the Temmler Group was acquired, and at the beginning of 2014 Haupt Pharma was acquired. The majority shareholder of Aenova is Kühne Holding AG.